MA47438A - Structure secondaire de polynucléotide - Google Patents
Structure secondaire de polynucléotideInfo
- Publication number
- MA47438A MA47438A MA047438A MA47438A MA47438A MA 47438 A MA47438 A MA 47438A MA 047438 A MA047438 A MA 047438A MA 47438 A MA47438 A MA 47438A MA 47438 A MA47438 A MA 47438A
- Authority
- MA
- Morocco
- Prior art keywords
- polynucleotide structure
- secondary polynucleotide
- polynucleotide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
- A61K48/0066—Manipulation of the nucleic acid to modify its expression pattern, e.g. enhance its duration of expression, achieved by the presence of particular introns in the delivered nucleic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762453482P | 2017-02-01 | 2017-02-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA47438A true MA47438A (fr) | 2019-12-11 |
Family
ID=63041198
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA047438A MA47438A (fr) | 2017-02-01 | 2018-02-01 | Structure secondaire de polynucléotide |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20200032274A1 (fr) |
| EP (1) | EP3577221A4 (fr) |
| MA (1) | MA47438A (fr) |
| WO (1) | WO2018144778A1 (fr) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| BR112016024644A2 (pt) | 2014-04-23 | 2017-10-10 | Modernatx Inc | vacinas de ácido nucleico |
| US11364292B2 (en) | 2015-07-21 | 2022-06-21 | Modernatx, Inc. | CHIKV RNA vaccines |
| EP3324979B1 (fr) | 2015-07-21 | 2022-10-12 | ModernaTX, Inc. | Vaccins contre une maladie infectieuse |
| WO2017031232A1 (fr) | 2015-08-17 | 2017-02-23 | Modernatx, Inc. | Procédés de préparation de particules et compositions associées |
| EP3364981A4 (fr) | 2015-10-22 | 2019-08-07 | ModernaTX, Inc. | Vaccin contre le cytomégalovirus humain |
| CA3002819A1 (fr) | 2015-10-22 | 2017-04-27 | Modernatx, Inc. | Vaccins contre les maladies sexuellement transmissibles |
| CA3002912A1 (fr) | 2015-10-22 | 2017-04-27 | Modernatx, Inc. | Vaccins a base d'acide nucleique contre le virus varicelle-zona (vzv) |
| EP3364950A4 (fr) | 2015-10-22 | 2019-10-23 | ModernaTX, Inc. | Vaccins contre des maladies tropicales |
| EP4011451A1 (fr) | 2015-10-22 | 2022-06-15 | ModernaTX, Inc. | Vaccins contre le virus respiratoire |
| EP3964200A1 (fr) | 2015-12-10 | 2022-03-09 | ModernaTX, Inc. | Compositions et procédés permettant d'administrer des agents thérapeutiques |
| US10465190B1 (en) | 2015-12-23 | 2019-11-05 | Modernatx, Inc. | In vitro transcription methods and constructs |
| KR102533456B1 (ko) | 2016-05-18 | 2023-05-17 | 모더나티엑스, 인크. | 릴랙신을 인코딩하는 폴리뉴클레오타이드 |
| CN116837052A (zh) | 2016-09-14 | 2023-10-03 | 摩登纳特斯有限公司 | 高纯度rna组合物及其制备方法 |
| JP6980780B2 (ja) | 2016-10-21 | 2021-12-15 | モデルナティーエックス， インコーポレイテッド | ヒトサイトメガロウイルスワクチン |
| US10925958B2 (en) | 2016-11-11 | 2021-02-23 | Modernatx, Inc. | Influenza vaccine |
| US11103578B2 (en) | 2016-12-08 | 2021-08-31 | Modernatx, Inc. | Respiratory virus nucleic acid vaccines |
| US11384352B2 (en) | 2016-12-13 | 2022-07-12 | Modernatx, Inc. | RNA affinity purification |
| WO2018151816A1 (fr) | 2017-02-16 | 2018-08-23 | Modernatx, Inc. | Compositions immunogènes très puissantes |
| MA52262A (fr) | 2017-03-15 | 2020-02-19 | Modernatx Inc | Vaccin à large spectre contre le virus de la grippe |
| US11752206B2 (en) | 2017-03-15 | 2023-09-12 | Modernatx, Inc. | Herpes simplex virus vaccine |
| US11045540B2 (en) | 2017-03-15 | 2021-06-29 | Modernatx, Inc. | Varicella zoster virus (VZV) vaccine |
| MA47787A (fr) | 2017-03-15 | 2020-01-22 | Modernatx Inc | Vaccin contre le virus respiratoire syncytial |
| MA47790A (fr) | 2017-03-17 | 2021-05-05 | Modernatx Inc | Vaccins à base d'arn contre des maladies zoonotiques |
| US11905525B2 (en) | 2017-04-05 | 2024-02-20 | Modernatx, Inc. | Reduction of elimination of immune responses to non-intravenous, e.g., subcutaneously administered therapeutic proteins |
| US11786607B2 (en) | 2017-06-15 | 2023-10-17 | Modernatx, Inc. | RNA formulations |
| EP3668979A4 (fr) | 2017-08-18 | 2021-06-02 | Modernatx, Inc. | Procédés pour analyse par clhp |
| WO2019036682A1 (fr) | 2017-08-18 | 2019-02-21 | Modernatx, Inc. | Variants d'arn polymérase |
| EP3668977A4 (fr) | 2017-08-18 | 2021-04-21 | Modernatx, Inc. | Procédés analytiques par hplc |
| WO2019046809A1 (fr) | 2017-08-31 | 2019-03-07 | Modernatx, Inc. | Procédés de fabrication de nanoparticules lipidiques |
| US10653767B2 (en) | 2017-09-14 | 2020-05-19 | Modernatx, Inc. | Zika virus MRNA vaccines |
| MA54676A (fr) | 2018-01-29 | 2021-11-17 | Modernatx Inc | Vaccins à base d'arn contre le vrs |
| US11351242B1 (en) | 2019-02-12 | 2022-06-07 | Modernatx, Inc. | HMPV/hPIV3 mRNA vaccine composition |
| US11851694B1 (en) | 2019-02-20 | 2023-12-26 | Modernatx, Inc. | High fidelity in vitro transcription |
| MA55037A (fr) | 2019-02-20 | 2021-12-29 | Modernatx Inc | Variants d'arn polymérase pour le coiffage co-transcriptionnel |
| GB2594365B (en) | 2020-04-22 | 2023-07-05 | BioNTech SE | Coronavirus vaccine |
| EP4179112A2 (fr) | 2020-07-13 | 2023-05-17 | The Board of Trustees of the Leland Stanford Junior University | Systèmes et procédés d'évaluation de la stabilité de l'arn |
| US11406703B2 (en) | 2020-08-25 | 2022-08-09 | Modernatx, Inc. | Human cytomegalovirus vaccine |
| US11492611B2 (en) | 2020-08-31 | 2022-11-08 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for producing RNA constructs with increased translation and stability |
| US11524023B2 (en) | 2021-02-19 | 2022-12-13 | Modernatx, Inc. | Lipid nanoparticle compositions and methods of formulating the same |
| CN117730157A (zh) * | 2022-04-15 | 2024-03-19 | 萨默费尼根有限公司 | 用于定量监测mRNA加帽效率的方法 |
| WO2023235820A1 (fr) * | 2022-06-03 | 2023-12-07 | Eclipse Bioinnovations, Inc. | Procédés d'obtention d'une structure secondaire d'arn d'arn encapsulé dans une npl |
| US11878055B1 (en) | 2022-06-26 | 2024-01-23 | BioNTech SE | Coronavirus vaccine |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2305699B1 (fr) | 2001-06-05 | 2014-08-13 | CureVac GmbH | ARNm stabilisée avec un contenu augmenté en G/C et optimisée pour la translation dans ses zones codées pour la vaccination contre la trypanosomiase, la leishmaniose et la toxoplasmose |
| US8768630B2 (en) * | 2010-02-19 | 2014-07-01 | The Regents Of The University Of Michigan | miRNA target prediction |
| WO2011156539A2 (fr) * | 2010-06-11 | 2011-12-15 | Syngenta Participations Ag | Compositions et procédés de production de protéines |
| EP3682905B1 (fr) * | 2011-10-03 | 2021-12-01 | ModernaTX, Inc. | Nucléosides, nucléotides et acides nucléiques modifiés et leurs utilisations |
| EP2931319B1 (fr) * | 2012-12-13 | 2019-08-21 | ModernaTX, Inc. | Molécules d'acide nucléique modifiées et leurs utilisations |
| EP2983804A4 (fr) | 2013-03-15 | 2017-03-01 | Moderna Therapeutics, Inc. | Purification d'arnm par échange d'ions |
| US10077439B2 (en) | 2013-03-15 | 2018-09-18 | Modernatx, Inc. | Removal of DNA fragments in mRNA production process |
| WO2014144039A1 (fr) | 2013-03-15 | 2014-09-18 | Moderna Therapeutics, Inc. | Caractérisation de molécules d'arnm |
| US10138507B2 (en) | 2013-03-15 | 2018-11-27 | Modernatx, Inc. | Manufacturing methods for production of RNA transcripts |
| WO2014152031A1 (fr) | 2013-03-15 | 2014-09-25 | Moderna Therapeutics, Inc. | Purification d'acide ribonucléique |
| WO2014144711A1 (fr) | 2013-03-15 | 2014-09-18 | Moderna Therapeutics, Inc. | Analyse de l'hétérogénéité et de la stabilité d'arnm |
| PL3146924T3 (pl) | 2015-09-24 | 2023-03-20 | Medinice S.A. | Krioaplikator do mało-inwazyjnej ablacji kardiochirurgicznej |
-
2018
- 2018-02-01 EP EP18748592.5A patent/EP3577221A4/fr active Pending
- 2018-02-01 US US16/483,012 patent/US20200032274A1/en not_active Abandoned
- 2018-02-01 WO PCT/US2018/016514 patent/WO2018144778A1/fr unknown
- 2018-02-01 MA MA047438A patent/MA47438A/fr unknown
-
2023
- 2023-01-04 US US18/093,119 patent/US20230250439A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20230250439A1 (en) | 2023-08-10 |
| WO2018144778A1 (fr) | 2018-08-09 |
| US20200032274A1 (en) | 2020-01-30 |
| EP3577221A4 (fr) | 2020-12-23 |
| EP3577221A1 (fr) | 2019-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA47438A (fr) | Structure secondaire de polynucléotide | |
| GB2552554B (en) | Resource arrangement | |
| BR112017013444A2 (pt) | aperfeiçoamento de procedimento de rach de lte | |
| ZA201900609B (en) | Sulfonamides as gpr40- and gpr120-agonists | |
| ZA202001147B (en) | Construction component | |
| FR3023009B1 (fr) | Radar secondaire | |
| GB2549996B8 (en) | Structures | |
| HK1247236A1 (zh) | 效能分析 | |
| FR3032494B1 (fr) | Aube de soufflante | |
| FI11882U1 (fi) | Sähkökytkin | |
| BR112018000296A2 (pt) | ensaios de potência de influenza | |
| GB201722178D0 (en) | Y | |
| GB201704620D0 (en) | Combinations | |
| PL3420148T3 (pl) | Rynna | |
| GB201810256D0 (en) | Polynucleotide | |
| PL3505703T3 (pl) | Układ odpływowy | |
| ES1197158Y (es) | Clema de conexion rapida | |
| UY4606S (es) | Evolucion | |
| ES1189384Y (es) | Composicion de ginebra | |
| ES1206336Y (es) | Conjunto de climatizacion | |
| TH178767B (th) | ถ้วย | |
| IT201700089117A1 (it) | Bisturi perfezionato | |
| IT201700055102A1 (it) | Estrattore multilinea | |
| UA36522S (uk) | Чарка | |
| FR3042316B1 (fr) | Structure de radar |